September 1, 2022
FDA: Class I recall of Hamilton-C6 Intensive Care Ventilator
Editor's Note
The Food and Drug Administration (FDA) on August 29 identified the recall by Hamilton Medical AG of its Hamilton-C6 Intensive Care Ventilator as Class I, the most serious.
The recall was initiated because of potential water ingress between the indicator board and the ventilator’s main board that may cause breathing support to stop.
To date, there have been 128 complaints (worldwide), no injuries, and no deaths associated with this issue.
Distribution dates were August31, 2017, to May 20, 2022.
Free Daily News
- Joint Commission International launches healthcare sustainability certification for global organizations
- Study: Right-sized donor livers scarce for female cancer patients
- NYU Langone surgeons complete first fully robotic lung transplant in US
- Study: C-sections more likely for black women
- Study: Tubal ligation surgeries surged after abortion restrictions
- Congressional hearing exposes US organ transplant system failures
- Researchers in Zurich, Hong Kong celebrate remote surgery milestone with successful pig endoscopy
- Study: Preoperative depression boosts risk of postoperative delirium
- Trump-Harris debate highlights contrast on abortion, Affordable Care Act
- Countdown to OR Manager Conference: Robotics in the ASC—Technology trends and what you need to know
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement